Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 16 of 21 found articles
 
 
  Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08–2015 ENERGY): a randomised, open-label, phase 3 study
 
 
Title: Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08–2015 ENERGY): a randomised, open-label, phase 3 study
Author: Léna, Hervé
Greillier, Laurent
Cropet, Claire
Bylicki, Olivier
Monnet, Isabelle
Audigier-Valette, Clarisse
Falchero, Lionel
Vergnenègre, Alain
Demontrond, Pierre
Geier, Margaux
Guisier, Florian
Hominal, Stéphane
Locher, Chrystèle
Corre, Romain
Chouaid, Christos
Ricordel, Charles
Appeared in: Lancet respiratory medicine
Paging: Volume 13 () nr. 2 pages 141-152
Year: 2025
Contents:
Publisher: Elsevier Ltd
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 16 of 21 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands